ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $909 | -99.8% | 145,953 | +74.7% | 0.00% | 0.0% |
| Q3 2022 | $559,000 | +171.4% | 83,568 | +158.0% | 0.00% | – |
| Q2 2022 | $206,000 | -21.1% | 32,392 | -42.6% | 0.00% | – |
| Q1 2022 | $261,000 | +44.2% | 56,427 | +55.5% | 0.00% | – |
| Q4 2021 | $181,000 | -91.1% | 36,291 | -78.6% | 0.00% | -100.0% |
| Q3 2021 | $2,041,000 | +257.4% | 169,400 | +527.4% | 0.00% | +100.0% |
| Q2 2021 | $571,000 | -34.7% | 27,000 | +123.0% | 0.00% | 0.0% |
| Q1 2018 | $875,000 | +641.5% | 12,106 | +734.9% | 0.00% | – |
| Q2 2015 | $118,000 | -95.1% | 1,450 | -94.5% | 0.00% | -100.0% |
| Q1 2015 | $2,430,000 | +30275.0% | 26,245 | +13022.5% | 0.01% | – |
| Q4 2014 | $8,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |